Progyny (PGNY) saw its shares surge in the last session with trading volume being higher than averag

Investors interested in Medical Services stocks are likely familiar with Progyny (PGNY) and Charles

Expecting 1.2 Million New Covered Lives from Commitments to Date and Anticipated Remaining Decisions

Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and

JP Morgan analyst Lisa Gill maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price t

Wells Fargo analyst Stan Berenshteyn initiates coverage on Progyny (NASDAQ:PGNY) with a Overweigh

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and raises t

Barclays analyst Peter Warendorf maintains Progyny (NASDAQ:PGNY) with a Equal-Weight and lowers t

Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The

Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market

Progyny (NASDAQ:PGNY) is looking for Q3 Adj EPS of $0.50-$0.52 vs $0.33 analyst estimate. sees sales

Progyny (NASDAQ:PGNY) raises FY2026 Adj EPS guidance from $1.98-$2.09 to $2.04-$2.10 vs $1.29 analys

Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.55 per share which beat the analyst consensu

Wall Street analysts change outlook on top stocks. See upgrade, downgrade, and initiation changes on

Barclays analyst Peter Warendorf downgrades Progyny (NASDAQ:PGNY) from Overweight to Equal-Weight

BTIG analyst David Larsen maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target

Canaccord Genuity analyst Richard Close maintains Progyny (NASDAQ:PGNY) with a Buy and raises the

Warning: RSI is above 70 for 3 overbought stocks in healthcare. Progyny, 10X Genomics, and Privia He

Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and raises t

B of A Securities analyst Michael Cherny maintains Progyny (NASDAQ:PGNY) with a Buy and raises th

Top Wall Street analysts upgraded STUB, PGNY, AMT, and BAP stocks and raised their price targets. Se

Canaccord Genuity analyst Richard Close upgrades Progyny (NASDAQ:PGNY) from Hold to Buy and raise

Barclays analyst Glen Santangelo maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and raises t

Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and

Progyny (NASDAQ:PGNY) is looking for Q2 Adj EPS of $0.50-$0.53 vs $0.33 analyst estimate. sees sales

Progyny (NASDAQ:PGNY) raises FY2026 Adj EPS guidance from $1.83-$1.95 to $1.98-$2.09 vs $1.32 analys

Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.50 per share which beat the analyst consensu

Available in the U.S., Progyny Select enables small employers to have access to fertility solutions

Barclays analyst Glen Santangelo maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the

On March 13, 2026, Progyny, Inc. (the "Company") issued a Notice of Pendency of Settlement o

Canaccord Genuity analyst Richard Close maintains Progyny (NASDAQ:PGNY) with a Hold and lowers th

Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and lowers t

Progyny (NASDAQ:PGNY) is looking for Q1 Adj EPS of $0.42-$0.45 vs $0.39 analyst estimate. sees sales

Progyny (NASDAQ:PGNY) is looking for FY2026 Adj EPS of $1.83-$1.95 vs $1.55 analyst estimate. sees s

Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.48 per share which beat the analyst consensu

Citizens analyst Constantine Davides upgrades Progyny (NASDAQ:PGNY) from Market Perform to Market

Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the

Barclays analyst Glen Santangelo initiates coverage on Progyny (NASDAQ:PGNY) with a Overweight ra

https://www.politico.com/newsletters/inside-congress/2025/11/24/trumps-obamacare-move-blindsides-con